Android app Apple app link

J.P. Morgan Maintains a Buy Rating on AstraZeneca PLC (AZN), Sets a £140 PT

By Yahoo! Finance   |   1 month ago
J.P. Morgan Maintains a Buy Rating on AstraZeneca PLC (AZN), Sets a £140 PT

AstraZeneca (NASDAQ:AZN) is a top low-volatility stock to consider buying. J.P. Morgan analyst upgraded the stock to Buy with a £140 price target following positive trial results for Datroway in breast cancer treatment.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.